Wooin Lee

6.6k total citations · 1 hit paper
168 papers, 5.1k citations indexed

About

Wooin Lee is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, Wooin Lee has authored 168 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Oncology, 63 papers in Molecular Biology and 37 papers in Hematology. Recurrent topics in Wooin Lee's work include Drug Transport and Resistance Mechanisms (38 papers), Multiple Myeloma Research and Treatments (20 papers) and Ubiquitin and proteasome pathways (19 papers). Wooin Lee is often cited by papers focused on Drug Transport and Resistance Mechanisms (38 papers), Multiple Myeloma Research and Treatments (20 papers) and Ubiquitin and proteasome pathways (19 papers). Wooin Lee collaborates with scholars based in South Korea, United States and Japan. Wooin Lee's co-authors include Richard B. Kim, Brenda F. Leake, Rommel G. Tirona, Hartmut Glaeser, Kyung Bo Kim, Ji Eun Park, A. Craig Lockhart, Richard Ho, Yi Wang and Richard Roberts and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Wooin Lee

161 papers receiving 5.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Drug and Bile Acid Transporters in Rosuvastatin Hepatic Uptake: Function, Expression, and Pharmacogenetics

2006 500 citations Wooin Lee et al. profile →

Peers

Countries citing papers authored by Wooin Lee

Since Specialization

Citations

This map shows the geographic impact of Wooin Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wooin Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wooin Lee more than expected).

Fields of papers citing papers by Wooin Lee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wooin Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wooin Lee. The network helps show where Wooin Lee may publish in the future.

Co-authorship network of co-authors of Wooin Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Wooin Lee. A scholar is included among the top collaborators of Wooin Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wooin Lee. Wooin Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Predicting In Vivo Target Occupancy (TO) Profiles via Physiologically Based Pharmacokinetic–TO Modeling of Warfarin Pharmacokinetics in Blood: Importance of Low Dose Data and Prediction of Stereoselective Target Interactions	Drug Metabolism and Disposition	Wooin Lee, Min‐Soo Kim et al.	8
2	Correction to: Connectivity map-based drug repositioning of bortezomib to reverse the metastatic effect of GALNT14 in lung cancer	Oncogene	Haeseung Lee, Ji Eun Park et al.	1
3	Revisiting Nonlinear Bosentan Pharmacokinetics by Physiologically Based Pharmacokinetic Modeling: Target Binding, Albeit Not a Major Contributor to Nonlinearity, Can Offer Prediction of Target Occupancy	Drug Metabolism and Disposition	Kota Toshimoto, Wooin Lee et al.	13
4	Pharmacokinetic aspects of the clinically used proteasome inhibitor drugs and efforts toward nanoparticulate delivery systems	Journal of Pharmaceutical Investigation	Kyung Bo Kim, Yoon Yeo et al.	6
5	Analysis of the Current Status of Liver Cancer Screening Institutions and Proficiency of Institutions that Conduct Alpha-fetoprotein Tests	Laboratory Medicine Online	Taek Soo Kim, Junghan Song et al.	0
6	Macrocyclic Immunoproteasome Inhibitors as a Potential Therapy for Alzheimer’s Disease	Journal of Medicinal Chemistry	Min Jae Lee, Deepak Bhattarai et al.	11
7	Post-translational regulation of the major drug transporters in the families of organic anion transporters and organic anion–transporting polypeptides	Journal of Biological Chemistry	Wooin Lee, Yuichi Sugiyama et al.	28
8	Connectivity map-based drug repositioning of bortezomib to reverse the metastatic effect of GALNT14 in lung cancer	Oncogene	Haeseung Lee, Ji Eun Park et al.	31
9	Expanding therapeutic utility of carfilzomib for breast cancer therapy by novel albumin-coated nanocrystal formulation	Journal of Controlled Release	Ji Eun Park, Joonyoung Park et al.	48
10	H727 cells are inherently resistant to the proteasome inhibitor carfilzomib, yet require proteasome activity for cell survival and growth	Scientific Reports	Min Jae Lee, Zachary Miller et al.	12
11	Next-generation proteasome inhibitors for cancer therapy	Translational research	Ji Eun Park, Zachary Miller et al.	110
12	Polymer micelle formulation for the proteasome inhibitor drug carfilzomib: Anticancer efficacy and pharmacokinetic studies in mice	PLoS ONE	Ji Eun Park, Derek Reichel et al.	33
13	Essential Role of DNA Methyltransferase 1–mediated Transcription of Insulin-like Growth Factor 2 in Resistance to Histone Deacetylase Inhibitors	Clinical Cancer Research	Hye‐Young Min, Su-Chan Lee et al.	21
14	Middle East Respiratory Syndrome Coronavirus Transmission in Dialysis Unit and Infection Control Interventions in Korea	Infection Control and Hospital Epidemiology	Jun Seong Son, Yu Ho Lee et al.	5
15	Novel Mechanistic Insights into Ectodomain Shedding of EGFR Ligands Amphiregulin and TGF-α: Impact on Gastrointestinal Cancers Driven by Secondary Bile Acids	Cancer Research	Nagaraj S. Nagathihalli, Yugandhar Beesetty et al.	96
16	A FRET-based approach for identification of proteasome catalytic subunit composition	Molecular BioSystems	Ji Eun Park, Ying Wu et al.	12
17	Revisiting the role of the immunoproteasome in the activation of the canonical NF-κB pathway	Molecular BioSystems	Eun Ryoung Jang, Nara Lee et al.	26
18	Phase I Pharmacokinetic and Pharmacodynamic Study of SJG-136, a Novel DNA Sequence Selective Minor Groove Cross-linking Agent, in Advanced Solid Tumors	Clinical Cancer Research	Igor Puzanov, Wooin Lee et al.	35
19	Evaluation of BNP Assays with Access 2 and AxSYM BNP in Comparison with Point-of-Care Triage BNP assay	The Korean Journal of Laboratory Medicine	Jin‐Tae Suh, Myung‐Hee Kim et al.	0
20	Clinical Evaluation of 10 Cases of Nontuberculous Mycobacteria Isolated from Sputum	The Korean Journal of Laboratory Medicine	Jun-Sik Kim, Jin‐Tae Suh et al.	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact